Latest News

  • INVESTMENT

    23 Feb 2026

    Cracking the Brain’s Code: Aerska’s $39M Leap
  • RESEARCH

    13 Feb 2026

    Nose Knows: A New Route Into the Brain
  • PARTNERSHIPS

    10 Feb 2026

    Can Early Partnerships Fix the ADC Bottleneck?
  • TECHNOLOGY

    4 Feb 2026

    Europe’s Drugmakers Turn to AI to Cut Risk and Gain Speed

Europe’s Drug Delivery Makeover Is Already Underway!

Injectable vials and capsules symbolising subcutaneous drug delivery platforms

INNOVATION

26 Dec 2025

New delivery platforms are reshaping European care, enabling simpler dosing, outpatient treatment, and earlier formulation planning

Golden capsule spheres forming an arrow with one cut open on white background

PARTNERSHIPS

15 Dec 2025

A Small Deal With Big Implications for Drug Design

A licence-and-option agreement in Sweden shows how delivery systems are becoming part of early drug strategy, not a late-stage add-on

Gloved hand holding capsule with digital data overlay

TECHNOLOGY

9 Dec 2025

From Prescription to Practice: Cloud Tech Transforms Drug Delivery

Connected drug delivery is improving adherence data and real-world insight, but reimbursement and system integration remain uneven across ...

European Medicines Agency headquarters building exterior

REGULATORY

2 Dec 2025

EMA Guidance Brings Sharper Focus to Drug Delivery in Europe

Updated EMA guidance clarifies how drug-device products are regulated, shaping planning, partnerships, and investment priorities across Eu...

Novartis headquarters building exterior with company logo

INVESTMENT

28 Oct 2025

Novartis Deal Puts Drug Delivery at the Center of Pharma

$12bn Avidity acquisition highlights delivery platforms as a strategic focus for drugmakers developing RNA therapies

Ypsomed corporate office building with company signage

PARTNERSHIPS

5 Aug 2025

Focus Over Footprint: What Ypsomed’s Sale Reveals

Ypsomed’s August 2025 diabetes exit signals a wider medtech shift toward tighter focus, scalable platforms, and simpler self-injection too...

Inhaler device representing low-GWP respiratory drug delivery

INNOVATION

29 Jul 2025

Breathing Easier, With a Smaller Carbon Cost

EU regulators back low-GWP inhalers, signaling how sustainability is reshaping drug delivery without disrupting patient care

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.